Introducing Starlite-AI: Our Latest Step Toward Intelligent Clinical Trial Optimization
Our advanced AI model built to transform clinical trials with automation, streamlined design, data-driven recommendations, and insights across millions of data points.
Announcing the Aurora Suite™ Teaser Video: A Glimpse into the Future of Clinical Trials
We are thrilled to announce the release of our Aurora Suite™ Teaser Video! This exciting video provides a sneak peek into the revolutionary capabilities of our suite of tools designed to transform the clinical trial landscape.
Aurora Analytica Article Published by Applied Clinical Trials Magazine
Our article delves into the most pressing issues facing the pharmaceutical industry today, specifically around optimizing clinical trials. Backed by real-world perspectives gathered from our Aurora Analytica Insights Survey, we discuss views of industry stakeholders across Biotech, Pharma, and CROs.
Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024
Using the Aurora Suite we compared the phase III trial 'POLO' with our results. The Aurora Suite could have enabled POLO to enroll more than 200% higher, whilst reducing sites required and enrollment time by ~30%.
Aurora Analytica Presents at ESMO, Barcelona, 2024
We present our poster, "Revolutionizing Clinical Trials: Harnessing Artificial Intelligence for Optimized Phase III Studies in Pancreatic Cancer.
Aurora Analytica Receives Innovation Norway Grant to Drive Clinical Trial Optimization Innovation
We are thrilled to announce that Aurora Analytica has been awarded a prestigious grant from Innovation Norway.
Introducing Aurora Consulting
At the heart of Aurora Consulting's mission is a profound dedication to your project's triumph. Our foundation is built on understanding and addressing the pivotal questions that shape the landscape of healthcare innovation.
Aurora Analytica’s Pioneering Ready-to-Use Solutions for Immediate Impact
In an era where promises often outweigh performance, the frustration of waiting for a product to deliver on its claims is all too common. At Aurora Analytica, we understand this sentiment and have made it our mission to redefine the customer experience by offering solutions that are not only ready to use from day one but also continuously evolving to exceed your expectations.
Decoding the Global Puzzle
Decoding the Global Puzzle: Aurora Analytica's Geo Matrix™ Unravels Clinical Trial Country Selection Challenges
Aurora Analytica AS Secures Seed Funding to Fuel Product Development.
Oslo, Norway, 16th January 2024 – Aurora Analytica has successfully raised an undisclosed amount in seed funding. The funding will be used to accelerate the company's ongoing product development efforts and strengthen its position in the healthcare research sector.
Aurora Analytica AS Welcomes Bhavish Lekh as Chief Executive Officer.
Oslo, Norway, 14th December 2023 – Aurora Analytica AS, a pioneering healthcare analytics and data company, is delighted to announce the appointment of Bhavish Lekh as CEO.
Aurora Analytica AS Welcomes Dr Ola Gudmundsen as Chairman of the Board.
Oslo, Norway, 11th December 2023 – Aurora Analytica AS, a pioneering healthcare analytics and data company, is delighted to announce the appointment of Ola Gudmundsen to its board of directors, as Chairman of the Board.
Illuminating the Path: Introducing Aurora Analytica
We are thrilled to announce the birth of a new era in healthcare analytics: Aurora Analytica. At Aurora Analytica, we believe in the transformative power of data, and our mission is to empower healthcare pioneers to re-envision the possibilities within their reach.